Welcome Visitor Wednesday, April 17, 2024

Articles related to Warren Center for Neuroscience Drug Discovery


Vanderbilt IP licensed to IPO-prospect Neumora might earn VU millions
Vanderbilt IP licensed to IPO-prospect Neumora might earn VU millions

Scenario: VU could garner up to $422MM, as fight against neurospsych disorders, degenerative diseases advances.

Read More
Appello Pharma completes Series A to advance treatment of Parkinson's
Appello Pharma completes Series A to advance treatment of Parkinson's

[Updated] Less than three years into their mission, Deerfield, Mountain Group and founders press forward.

Read More

Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: